Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.Jonathan Kaye, Charles A. Janeway|The Journal of Experimental Medicine|1983Cited by 648
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M. Tu, Dan Theodorescu, Robert T. Jones et al.|Communications Biology|2020Cited by 170